The Renin System for Understanding Human Hypertension: Evidence for Blood Pressure Control by A Bipolar Vasoconstriction-Volume Mechanism. Prorenin as a Determinant of Renin Secretion
- 1 January 1982
- journal article
- Published by Taylor & Francis in Clinical and Experimental Hypertension. Part A: Theory and Practice
- Vol. 4 (11-12) , 2303-2337
- https://doi.org/10.3109/10641968209062392
Abstract
A body of evidence indicates that all hypertensive phenomena ranging from mild disorders to fulminant malignant hypertension can be profitably analyzed by assessing the relative contribution of two final determinants of the arterial blood pressure – the degree of arteriolar vasoconstriction and size of the volume filling the arterial tree. The latter function is largely determined by the state of sodium balance. Renin-sodium profiling and separate testing with specific pharmacologic probes are the basic tools for quantifying these factors in individual patients. This bidimensional analysis of blood pressure phenomena has considerable practical value for identifying and treating curable renovascular and adrenocortical forms. Beyond this, the analysis provides pathophysiologic information of practical value for characterizing and treating individual patients in the whole spectrum of human hypertensive diseases including essential hypertension. This new analytical scaffold also identifies key physiologic questions for future research. About 90 percent of the circulating renin occurs in an inactive form as a possible prorenin, which could be an important regulatory point for renin release. in response to stimuli prorenin rises and falls with active renin. Beta blockade may lower active renin by blocking the conversion process. At the physiological level the activation and/or release of renin appears to be primarily determined by sodium-volume changes perceived by a distal tubular mechanism.Keywords
This publication has 36 references indexed in Scilit:
- An intrinsic factor XII–prekallikrein-dependent pathway activates the human plasma renin–angiotensin systemNature, 1979
- Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patientsProgress in Cardiovascular Diseases, 1978
- PLASMA RENIN AND "PRORENIN" IN ESSENTIAL HYPERTENSION DURING SODIUM DEPLETION, BETA-BLOCKADE, AND REDUCED ARTERIAL PRESSUREThe Lancet, 1977
- Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting EnzymeNew England Journal of Medicine, 1977
- Estimating renin participation in hypertension: Superiority of converting enzyme inhibitor over saralasinThe American Journal of Medicine, 1976
- Renin as a risk factor in essential hypertension: More evidenceThe American Journal of Medicine, 1973
- Propranolol Inhibition of Renin SecretionNew England Journal of Medicine, 1972
- Hypertension of Renal Origin: Evidence for Two Different MechanismsScience, 1971
- Renin and Aldosterone Secretion in Man as Influenced by Changes in Electrolyte Balance and Blood VolumeCirculation Research, 1970
- Prolonged Infusions of Angiotensin II and Norepinephrine and Blood Pressure, Electrolyte Balance, and Aldosterone and Cortisol Secretion in Normal Man and in Cirrhosis with Ascites*Journal of Clinical Investigation, 1965